University of Chicago researchers assessed the long-term health outcomes and cost-effectiveness of four antiobesity medications compared to lifestyle modification alone. Results indicate that ...
Sociologist Jessica Calarco explains why the right keeps winning, and how progressive narratives can turn the tide ...
Tirzepatide and semaglutide were associated with larger QALY gains (incremental gains of 0.35 and 0.25 over lifestyle ...
A new study found that fair prices for medications like Wegovy and Zepbound would be hundreds less per month than they are ...
I agree with the House Budget Committee that our government's $36-trillion debt is a problem. But who should sacrifice to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results